The follow genetic alterations in KRAS, SMAD4, and TP53 further promoted the transition of adenoma to CRC by activating EGFR, P53 and TGF-β pathways (Drost et al., 2015; Chen et al., 2016). This evidence concerns the gene SMAD4 and colorectal carcinoma.